Cash Flow Statement
Quarterly Data
The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.
The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.
Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
The financial data reveals a period of significant volatility in cash flows, characterized by substantial fluctuations in operating activities and strategic shifts in investing and financing behaviors. While net earnings generally remained positive and grew from 2021 through 2023, the subsequent periods exhibit sharp deviations attributed to non-recurring events and strategic structural changes.
- Operating Cash Flow Dynamics
- Cash flows from operating activities demonstrate extreme quarterly variance. A peak was observed in the third quarter of 2022 at 18.5 billion USD, contrasted by significant outflows in the fourth quarters of 2022 and 2023. This volatility is largely driven by swings in unearned revenues and other operating items. Accounts receivable and medical costs payable exhibit cyclical patterns, often offsetting each other, though large outflows in accounts receivable are noted periodically, particularly in the first quarters of several years.
- Investing Activity and Capital Allocation
- Investing activities are consistently characterized by net outflows, reflecting a strategy of continuous growth and asset acquisition. Expenditures for property, equipment, and capitalized software show a steady upward trajectory, rising from approximately 560 million USD per quarter in 2021 to over 850 million USD by late 2026. A massive outflow of 14.3 billion USD for acquisitions occurred in December 2022. More recently, beginning in March 2025, a new pattern of loan originations and purchases emerged, with quarterly outflows exceeding 1 billion USD.
- Financing Strategy and Shareholder Returns
- Financing activities indicate a disciplined approach to shareholder returns coupled with opportunistic debt management. Cash dividends paid have grown steadily from approximately 1.2 billion USD per quarter in 2021 to over 2 billion USD per quarter by 2026. Common share repurchases are executed sporadically and in varying magnitudes, with significant buybacks noted in the fourth quarter of 2024. The company utilizes both short-term and long-term debt to manage liquidity, evidenced by large periodic issuances of long-term debt, such as the 11.8 billion USD infusion in September 2024.
- Analysis of Non-Recurring and Exceptional Items
- Several anomalous events heavily impacted the cash flow profile. A substantial loss on the sale of subsidiaries totaling over 7 billion USD was recorded in March 2024, which contributed to a corresponding dip in net earnings. Additionally, a specific liquidity event related to a cyberattack is evident, with massive loan outflows to care providers in early 2024, followed by a gradual recovery of those funds through repayments over subsequent quarters.
- Asset and Liability Management
- Depreciation and amortization expenses have maintained a consistent growth trend, increasing from 758 million USD in March 2021 to 1.07 billion USD by September 2026, indicating an expanding base of depreciable assets. The management of investments shows a continuous cycle of purchases and sales, with a notable spike in investment sales and purchases in late 2024, suggesting a rebalancing of the portfolio.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?